(-1.08%) 5 060.99 points
(-1.19%) 37 928 points
(-1.26%) 15 781 points
(-1.13%) $81.70
(-2.71%) $1.975
(-2.28%) $2 304.00
(-3.72%) $26.63
(-1.50%) $947.10
(0.47%) $0.937
(1.06%) $11.10
(0.49%) $0.800
(0.16%) $93.45
Live Chart Being Loaded With Signals
LENZ Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing aceclidine-based eye drop to enhance vision in patients diagnosed with presbyopia...
Stats | |
---|---|
Today's Volume | 338 336 |
Average Volume | 260 695 |
Market Cap | 408.54M |
EPS | $-0.400 ( 2024-04-01 ) |
Next earnings date | ( $-0.840 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 0 |
ATR14 | $0.0970 (0.61%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-21 | Alpha Wave Ventures Gp, Ltd | Buy | 0 | Common Stock, par value $0.00001 per share |
2024-03-21 | Ra Capital Management, L.p. | Buy | 933 038 | Common Stock |
2024-03-21 | Ra Capital Management, L.p. | Buy | 2 386 301 | Common Stock |
2024-03-21 | Ra Capital Management, L.p. | Buy | 694 755 | Common Stock |
2024-03-21 | Ra Capital Management, L.p. | Buy | 64 971 | Common Stockj |
INSIDER POWER |
---|
98.19 |
Last 36 transactions |
Buy: 7 737 959 | Sell: 70 534 |
Volume Correlation
LENZ Therapeutics, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
LENZ Therapeutics, Inc. Correlation - Currency/Commodity
LENZ Therapeutics, Inc. Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-2.41M (0.00 %) |
EPS: | $-15.30 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-2.41M (0.00 %) |
EPS: | $-15.30 |
Financial Reports:
No articles found.
LENZ Therapeutics, Inc.
LENZ Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing aceclidine-based eye drop to enhance vision in patients diagnosed with presbyopia. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators